Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and sells pharmaceuticals and medical devices

Photocure ASA engages as a pharmaceutical company, which specializes in photodynamic technology.

It develops solutions for diseases such as bladder cancer, colorectal cancer, human papillomavirus (HPV) and precancerous lesions of the cervix, and acne.

Its products include Hexvix and Cysview, which are used for the detection of bladder cancer.

It also has several products under its pipeline such as Cevira, Visonac, and Lumacan.

The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.

Number of employees : 47 persons.
Sales per Businesses
20132014Delta
NOK (in Million)%NOK (in Million)%
Cancer78.5694%92.0171.4% +14.62%
Dermatology5.056%1.571.2% -221.37%
Sales per Regions
20132014Delta
NOK (in Million)%NOK (in Million)%
Norway83.62100%---
Partner Countries Europe--47.8937.1%-
Nordic Region--33.4225.9%-
United States--12.289.5%-
Managers
NameAgeSinceTitle
Kjetil Hestdal PhD, MD561997President, Chief Executive Officer & Media Contact
Bente-Lill Bjerkelund Romøren672014Chairman
Kathleen Deardorff PharmD572011Chief Operating Officer & IR Contact
Erik Dahl-2012Chief Financial Officer & IR Contact
Inger Ferner Heglund612006Vice President-Research & Development
Xavier Denis Yon762011Director
Synne Hermansen Røine, MBA372014Director
Tom Edward Pike56-Director
Lars Rønn52-Director
Grete Hogstad602005Vice President-Strategic Marketing
Shareholders
NameEquities%
Hunter Hall Investment Management Ltd. 2,957,334 13.8%
KLP Kapitalforvaltning AS 2,217,165 10.3%
Fondsfinans Kapitalforvaltning ASA 2,054,371 9.57%
Radiumhospitalets Forskningsstiftelse 2,029,000 9.45%
Alexander Brask Hansson 1,080,000 5.03%
Danske Capital AS 893,208 4.16%
MP Pensjon PK 850,000 3.96%
Skagen AS 626,466 2.92%
DNB Asset Management AS 509,578 2.37%
Bergen Kommunale Pensjonskasse 500,000 2.33%
Holdings
NameEquities%Valuation
PCI Biotech Holding ASA (PCIB) 1,726,00411.6%782,380 USD
Photocure ASA (PHO) 32,4760.15%154,203 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
ALLERGAN PLC
BRISTOL-MYERS SQU..
NOVO NORDISK A/S
SANOFI
GLAXOSMITHKLINE P..
BAYER AG
ELI LILLY AND CO
ASTRAZENECA PLC
TEVA PHARMACEUTIC..
ABBOTT LABORATORI..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
SHIRE PLC
VALEANT PHARMACEU..
MYLAN NV
Sector Pharmaceuticals
Photocure ASA : Connections
Radiumhospitalets Forskningsstiftelse
Elastagen Pty Ltd.
ClanoTech AB
Chester Valley Pharmaceuticals, Inc.
Michelson Diagnostics Ltd.
Clinique des Champs Elysees
Colosseum Smile Group AB
Goapharma SAS
Vaccibody AS
Medical Instill Technologies, Inc
Biosergen AS
Laboratoires Panpharma SA
Pressalit A/S
Company contact information
Photocure ASA
Hoffsveien 4
Oslo 0275

Phone : +47.22.06.22.10
Fax : +47.22.06.22.18
Web : www.photocure.com
© 2016 People , Fundamentals and Ownership